Sarah M. London is the CEO of Centene Corporation, a major player in the healthcare industry. Appointed on March 21, 2022, she brings significant experience to the role, having previously served as the Vice Chairman and a member of the...

Current Market Cap

$39.46B

Number of Employees

67.7K

Total Compensation

2022 - 2023

Trending up by 96.08% last year
Showing total compensation for the last 2022 - 2023

Stock

Down by -100.00% last year

Salary

Up by 3.01% last year

Bonus

Up by 0.00% last year

Other

Up by 29.36% last year

Year

2023

Total Compensation

$4.48M

Salary

$1.40M

Board Justification

The compensation philosophy is designed to create long-term stockholder value, attract and retain top executive talent, and foster a culture of risk management and compliance, with a strong emphasis on performance-based compensation.

Bonus

$2.79M

Board Justification

Annual cash incentive award based on performance metrics including Adjusted Diluted EPS, Enterprise & Individual Goals, and Quality metrics, with a funding rate of 133%.

Other

$285.34K

Board Justification

Includes 401(k) match, non-qualified deferred compensation match, life insurance, personal aircraft usage, and liability insurance.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock vested in 2023 as the focus was on performance-based awards that will vest in future periods.

Performance Metrics

Adjusted Diluted EPS, Enterprise & Individual Goals, and Quality metrics.

SEC Filing

From March 28, 2024

Sarah M. London

CEO of Centene

C

Education

Not specified

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

January 1, 1977 - 47 years ago

Is Founder?

No

Current Tenure

2 years 6 months (Mar 2022 - Present)

Previous Experience

Vice Chairman of Centene Corporation

View Holdings

Insider Holdings of Sarah M. London

CNC

$50.48M

$7.06M (16.26%)

Last Insider Trade

CNC

186,062 shares

CNC

Mar 15, 2024

Received